GSK-484

N/A

Report date: 2026/03/14 20:00:17
NME

Base Information

Drug NameGSK-484
Drug Alias NameGSK-484GSK484MMV1793192GSK4024484GSK-4024484 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-arginine deiminase type-4 inhibitors
TargetsProtein-arginine deiminase type-4
Therapy Area/IndicationsMalaria, FalciparumMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcMedicines for Malaria Venture
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcMedicines for Malaria Venture
Inactive CompaniesN/A
Active IndicationsMalaria, FalciparumMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A